Dr. Brandy Fureman has been with the National Institute of Neurological Disorders and Stroke (NINDS) since 2001, and is currently a Program Director in the Channels, Synapses and Circuits cluster. Her portfolio includes basic, translational and clinical epilepsy research, including clinical trials. She is responsible for identifying epilepsy research issues critical to NINDS and NIH, and for coordinating the Institute's Epilepsy Research Benchmarks. Dr. Fureman previously served as a Clinical Research Project Manager in the NINDS Clinical Trials Group where she was responsible for overseeing the NINDS Clinical Research Collaboration Network and a number of Data and Safety Monitoring Boards for Phase III clinical trials in epilepsy, head injury, and stroke rehabilitation. Dr. Fureman has also served as a Health Science Policy Analyst in the NINDS Office of Science Policy and Planning, and as a Presidential Management Fellow at the NINDS. Dr. Fureman graduated from Cedar Crest College with a B.S. in Genetic Engineering Technology and received her Ph.D. in Neuroscience from the Department of Neuroscience and Anatomy at the Pennsylvania State University College of Medicine. Her research interests focused on molecular and behavioral effects of ion channelopathy in episodic neurological disorders.
Active Funding Initiatives for Dr. Fureman
Last Modified May 31, 2013